BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34486882)

  • 1. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer.
    Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S
    Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of outcomes after chemoradiotherapy for cervical cancer by neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio.
    Yu J; Huang L; Dong T; Cao L
    J Obstet Gynaecol; 2024 Dec; 44(1):2361858. PubMed ID: 38864403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts survival and prognosis in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
    Yang D; Li P; Meng Z; Hu X; Huang Z; Huang H; Dong H; Qin Y; Chen C; Chen X; Li Z; Zhou Z; Li Y; Kang M
    Sci Rep; 2024 Apr; 14(1):9898. PubMed ID: 38688967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast Cancer.
    Wang C; Shi Q; Zhang G; Wu X; Yan W; Wan A; Xiong S; Yuan L; Tian H; Ma D; Jiang J; Qi X; Zhang Y
    Oncologist; 2024 May; 29(5):e635-e642. PubMed ID: 38431781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis.
    Ethier JL; Desautels D; Templeton A; Shah PS; Amir E
    Breast Cancer Res; 2017 Jan; 19(1):2. PubMed ID: 28057046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy.
    Şahin AB; Cubukcu E; Ocak B; Deligonul A; Oyucu Orhan S; Tolunay S; Gokgoz MS; Cetintas S; Yarbas G; Senol K; Goktug MR; Yanasma ZB; Hasanzade U; Evrensel T
    Sci Rep; 2021 Jul; 11(1):14662. PubMed ID: 34282214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma.
    Han S; Liu Y; Li Q; Li Z; Hou H; Wu A
    BMC Cancer; 2015 Sep; 15():617. PubMed ID: 26341881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non-small cell lung cancer undergoing stereotactic body radiotherapy.
    Fang F; Jia Z; Xie H; Cao Y; Zhu X; Yang XY; Guo X; Zhang H
    Clin Respir J; 2024 May; 18(5):e13749. PubMed ID: 38685745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index on short- and long-term outcome following surgery for spinal metastases.
    Ryvlin J; Kim SW; Hamad MK; Fourman MS; Eleswarapu A; Murthy SG; Gelfand Y; De la Garza Ramos R; Yassari R
    J Neurosurg Spine; 2024 Apr; 40(4):475-484. PubMed ID: 38157531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of circulating tumor cell and neutrophil-lymphocyte ratio to identify high-risk metastatic castration-resistant prostate cancer patients.
    Chong W; Zhang Z; Luo R; Gu J; Lin J; Wei Q; Li B; Myers R; Lu-Yao G; Kelly WK; Wang C; Yang H
    BMC Cancer; 2021 Jun; 21(1):655. PubMed ID: 34078304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer-Treated with Neoadjuvant Systemic Therapy.
    De Schepper M; Nguyen HL; Richard F; Rosias L; Lerebours F; Vion R; Clatot F; Berghian A; Maetens M; Leduc S; Isnaldi E; Molinelli C; Lambertini M; Grillo F; Zoppoli G; Dirix L; Punie K; Wildiers H; Smeets A; Nevelsteen I; Neven P; Vincent-Salomon A; Larsimont D; Duhem C; Viens P; Bertucci F; Biganzoli E; Vermeulen P; Floris G; Desmedt C
    Cancer Res Commun; 2024 Jan; 4(1):186-199. PubMed ID: 38147006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of systemic immune-inflammatory markers before and after treatment for pathological complete response in patients undergoing neoadjuvant therapy for breast cancer: a retrospective study of 1994 patients.
    Wang H; Huang Z; Xu B; Zhang J; He P; Gao F; Zhang R; Huang X; Shan M
    Clin Transl Oncol; 2024 Jun; 26(6):1467-1479. PubMed ID: 38190034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Neutrophil-Lymphocyte and Albumin-Globulin Ratios With Outcomes in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy or Upfront Surgery.
    Yang SH; Tey ML; Zhou S; Nitar P; Mariyah H; Sim Y; Kusumawidjaja G; Chay WY; Yong WF; Wong RX
    J Breast Cancer; 2024 Apr; 27(2):105-120. PubMed ID: 38529588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The correlation between preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and postoperative recurrence of chronic rhinosinusitis].
    Zhang Y; Li Z; Wang S; Guo D; Wang G
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Feb; 38(2):133-139. PubMed ID: 38297867
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between blood inflammatory indices and carotid intima-media thickness in the middle-aged and elderly adults.
    Zhang P; Cui D; Zhang P; Wang H; Hao Y; Ma J; Li Q; Zhang A; Li D; Li X
    J Stroke Cerebrovasc Dis; 2024 Jun; 33(6):107715. PubMed ID: 38608824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Mean Platelet Volume, Platelet Count, Neutrophil/ Lymphocyte Ratio and Platelet/Lymphocyte Ratio in the Euthyroid, Overt Hypothyroid and Subclinical Hyperthyroid Phases of Papillary Thyroid Carcinoma.
    Kutluturk F; Gul SS; Sahin S; Tasliyurt T
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):859-865. PubMed ID: 30727930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between neutrophil-lymphocyte ratio and platelet-lymphocyte ratio with the severity of COVID-19.
    Arini IA; Masyeni S; Widhidewi NW
    Narra J; 2024 Apr; 4(1):e262. PubMed ID: 38798835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postpartum Depression and Inflammatory Biomarkers of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Monocyte-Lymphocyte Ratio: A Prospective Observational Study.
    La Verde M; Luciano M; Fordellone M; Sampogna G; Lettieri D; Palma M; Torella D; Marrapodi MM; Di Vincenzo M; Torella M
    Gynecol Obstet Invest; 2024; 89(2):140-149. PubMed ID: 38346412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancer.
    Gu X; Gao XS; Cui M; Xie M; Peng C; Bai Y; Guo W; Han L; Gu X; Xiong W
    Oncotarget; 2016 Aug; 7(31):49878-49887. PubMed ID: 27409665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLR Outperforms Low Hemoglobin and High Platelet Count as Predictive and Prognostic Biomarker in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
    Young M; Tapia JC; Szabados B; Jovaisaite A; Jackson-Spence F; Nally E; Powles T
    Clin Genitourin Cancer; 2024 Jun; 22(3):102072. PubMed ID: 38615487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.